ArticlePediatric cardiology2026
Incomplete Kawasaki Disease Versus Non-severe Multisystem Inflammatory Syndrome in Children: Distinguishing Features from Contemporaneous Patients.
Article in Pediatric cardiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
21 authors.
Funding
Abstract
Kawasaki disease (KD) and multisystem inflammatory syndrome in children (MIS-C) share overlapping clinical features, making diagnosis challenging. We compared patients with incomplete KD to those with non-severe MIS-C to identify distinguishing characteristics. Patients were enrolled in the International KD Registry (01/2020-10/2023) from 40 centers across eight countries. Among 2146 MIS-C patients, 769 met criteria for non-severe confirmed MIS-C (no shock or ICU admission). Among 1358 KD patients, 146 met American Heart Association (AHA) criteria for confirmed incomplete KD and 372 were classified as unconfirmed incomplete KD. Demographics, clinical and laboratory features, treatment, and cardiac outcomes were compared. Non-severe MIS-C patients were significantly older (median 7.4 years) than both confirmed (2.3 years) and unconfirmed (2.5 years; p < 0.001) incomplete KD patients, and had different ethnic distributions with more Black and fewer East or South Asian patients. MIS-C patients had shorter fever duration, fewer classic KD features, and more gastrointestinal and respiratory symptoms. They demonstrated lower white blood cell counts but higher inflammatory markers and markers of organ dysfunction. Cardiac involvement differed: MIS-C patients had more myocardial dysfunction, including lower ejection fraction and higher cardiac biomarkers. Coronary artery involvement in MIS-C (median maximum z-score 1.3) was similar to unconfirmed incomplete KD (median z-score 1.3) but less than confirmed incomplete KD (median z-score 2.0; p < 0.01). Older age, distinct ethnicity, prominent gastrointestinal and respiratory symptoms, and multisystem inflammation with ventricular dysfunction but relatively less coronary artery involvement help distinguish non-severe MIS-C from incomplete KD.
Indexed as
Identifiers
42696153What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.